AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
Commensal Escherichia coli isolates are phylogenetically distributed amonggeographically distinct human populations
Authors: Duriez, P Clermont, O Bonacorsi, S Bingen, E Chaventre, A Elion, J Picard, B Denamur, E
Citation: P. Duriez et al., Commensal Escherichia coli isolates are phylogenetically distributed amonggeographically distinct human populations, MICROBI-SGM, 147, 2001, pp. 1671-1676
PPARs, metabolic disease and atherosclerosis
Authors: Fruchart, JC Staels, B Duriez, P
Citation: Jc. Fruchart et al., PPARs, metabolic disease and atherosclerosis, PHARMAC RES, 44(5), 2001, pp. 345-352
Reduced costs with bisoprolol treatment for heart failure - An economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II)
Authors: Bacquet, P Levy, E McGuire, A McMurray, J Merot, JL Paschen, B Remme, WJ Szucs, TD Klein, W Brunhuber, W Hofmann, R Kuhn, P Nesser, HJ Slany, J Weihs, W Wiedermann, C Wimmer, H van Mieghem, W Boland, J Chaudron, JM Jordaens, L Melchior, JP Aschermann, M Bruthansl, J Hradec, M Kolbel, F Semrad, B Haghfelt, T Hansen, JF Goetzsche, CO Hildebrandt, P Kassis, E Rasmussen, V Rokkedal, J Thomassen, A Groundstroem, K Uusimaa, P Le Heuzey, JY Aumont, MC Aupetit, JF Baille, N Baudouy, P Belin, A Bonneau, A Bonneric, G Bousser, JP Citron, B Dary, P Decoulx, E De Groote, P Denolle, T Dievart, F Duriez, P Eicher, JC Enjuto, G Ferriere, M Fournier, E Garandeau, M Gauthier, J Genest, M Gerbe, A Godenir, JP Guillot, B Guillot, JP Guillot, P Heno, P d'Ivernois, C Jean, M Kacet, S Kalle, R Komajda, M Lacroix, A Lallemand, R Lardoux, H Marquet, M Martin, M Martin, O Mery, D Mossaz, R Mothes, P Olive, T Ostorero, M Paganelli, F Page, E Pauly-Laubry, C Puel, J Rousseau, JF Roux, JJ Schenowitz, A Sourdais, K Tremel, F Verdun, A Witchiz, S Wolf, JE Hombach, V Assmann, I Beyer, T Bischoff, KO Darius, H Ertl, G Fleck, E Forster, K Freytag, F Gleichmann, U Haasis, R Henssge, R Hey, D Hesse, P Hofs, T Keck, M Klein, H Kromer, ET Kruls-Munch, J Luderitz, B Maisch, B Mitrovic, V Neubauer, S Osterziel, KJ Simon, H Spitzer, SG Stohring, R Taubert, G Teichmann, W Theisen, K Wende, W Wieser, H Zotz, R Bridges, A Adgey, J Ambepitiya, G Boon, N Boyle, RM Cowley, AJ Cripps, T Davies, MK Dunn, F Findlay, J Forsey, P Fyfe, T Gould, B Greenwood, TW Hubner, P Khan, S Lewis, P Mackay, A Maltz, M McArthur, J McLeod, A McLeod, D Metcalfe, M Millar-Craig, M Mills, P Nelson, JK Nicholls, D Oakley, GD Patterson, DLH Pohl, JEF Ray, S Silke, B Wilkinson, PR Preda, I Csanady, M Cserhalmi, L Edes, I Gesztesi, T Karpati, P Simon, K Tarjan, J Fogari, R Tramarin, R Galie, N Giani, P Milanese, U Scalvini, S Scrutinio, D Sechi, LA Tettamanti, F De Vito, F Crean, P McCann, H Mulcahy, D Sugrue, D van Hoogenhuyze, DCA van der Burgh, PH Ciampricotti, R van Dantzig, JM DenHartog, FR Henneman, JA van Kesteren, HAM Kragten, JA Liem, KL Limburg, A van der Linde, MR Linssen, GCM Pasteuning, H Penn, HJAM Van Rossum, P Schaafsma, HJ Schelling, A Sloos, R Wesdorp, JCL Korewicki, J Achremczyk, P Czestockowska, E Dowgird, M Dyduszynski, A Gorski, J Ilmurzynska, K Janicki, K Kornacewicz-Jach, Z Kraska, T Krzeminska-Pakula, M Kuch, J Nartowicz, E Petelenz, T Piwowarska, W Rawczynska-Englert, I Ruzyllo, W Swiatecka, G Tendera, M Wierzchowiecki, M Wodniecki, J Wojciechowoski, D Wrabec, K Wysocki, H Gomes, RS Ceia, MF Lousada, N Campos, JMM Providencia, LA de Moura, ALZC Marejev, VJ Aronov, DM Arutjunov, GP Bart, BJ Basechikin, SS Belenkov, JN Beloussov, JB Bokeria, OA Charchogljan, RA Doschytsin, V Fedorova, TA Glezer, MG Gorbachenkov, A",Gorshkov,"Gospodarenko, AL Ivashkin, VT Ivleva, AJ Kyrichenko, AA Lavrov, AA Lazebnik, LB Marynov, A Mazaev, VP Polejev, NR",Shpektor,"Sidorenko, BA Sobolev, KE Starodoubtsev, AK Storozhakhov, GI Syrkin, AL Zodionchenko, VS Zvereva, TV Murin, J Kaliska, G Rybar, R Valle, V Artaza, M Conthe, P Cruz, JM Garcia-Moll, M Lopez-Sendon, JL Martinez, A Monzon, F Ribas, M Roig, E Roldan, I Hoglund, C Ekdahl, S Hjelmaeus, L Lindberg, K Lofdahl, P Ulvenstam, G Warselius, L Follath, F Anghern, W Dubach, P Erne, P Gallino, A Moccetti, T Jmouro, AV Dargie, HJ Erdmann, E Follath, F Hoglund, C Lechat, P Sendon, JLL Mareyev, V Remme, WJ Sadowski, Z Seabra-Gomes, RJ Zannad, F Wehrlen-Grandjean, M Funck-Brentano, C Hansen, S Hohnloser, S Vanoli, E Jaillon, P De Baker, G Dahlstrom, U Hill, C Leizorovicz, A Burgnard, F Rolland, C Wiemann, H Verkenne, P Arab, T Cussac, N Dussous, V Haise, S Funck-Brentano, C
Citation: P. Bacquet et al., Reduced costs with bisoprolol treatment for heart failure - An economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II), EUR HEART J, 22(12), 2001, pp. 1021-1031
Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-1 with severe hypercholesterolaemia
Authors: Boullier, A Hennuyer, N Tailleux, A Furman, C Duverger, N Caillaud, JM Castro, G Fievet, C Fruchart, JC Duriez, P
Citation: A. Boullier et al., Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-1 with severe hypercholesterolaemia, CLIN SCI, 100(3), 2001, pp. 343-355
Evolution pattern of auto-antibodies against oxidized low-density lipoproteins in renal transplant recipients
Authors: Kandoussi, AM Glowacki, F Duriez, P Tacquet, A Fruchart, JC Noel, C
Citation: Am. Kandoussi et al., Evolution pattern of auto-antibodies against oxidized low-density lipoproteins in renal transplant recipients, NEPHRON, 89(3), 2001, pp. 303-308
Effect of the inflammation, chronic hyperglycemia, or malabsorption on theapolipoprotein A-IV concentration in type 1 diabetes mellitus and in diabetes secondary to chronic pancreatitis
Authors: Quilliot, D Walters, E Guerci, B Fruchart, JC Duriez, P Drouin, P Ziegler, O
Citation: D. Quilliot et al., Effect of the inflammation, chronic hyperglycemia, or malabsorption on theapolipoprotein A-IV concentration in type 1 diabetes mellitus and in diabetes secondary to chronic pancreatitis, METABOLISM, 50(9), 2001, pp. 1019-1024
Mutator natural Escherichia coli isolates have an unusual virulence phenotype
Authors: Picard, B Duriez, P Gouriou, S Matic, I Denamur, E Taddei, H
Citation: B. Picard et al., Mutator natural Escherichia coli isolates have an unusual virulence phenotype, INFEC IMMUN, 69(1), 2001, pp. 9-14
PPAR alpha agonists inhibit tissue factor expression in human monocytes and macrophages
Authors: Neve, BP Corseaux, D Chinetti, G Zawadzki, C Fruchart, JC Duriez, P Staels, B Jude, B
Citation: Bp. Neve et al., PPAR alpha agonists inhibit tissue factor expression in human monocytes and macrophages, CIRCULATION, 103(2), 2001, pp. 207-212
Fundamental basis of atherosclerosis disease
Authors: Fruchart, JC Duriez, P
Citation: Jc. Fruchart et P. Duriez, Fundamental basis of atherosclerosis disease, ANN ENDOCR, 62(2), 2001, pp. 93-100
New conceptions in the mechanism of action of fibrates and prospective therapeutics in atherosclerosis
Authors: Fruchart, JC Staels, B Duriez, P
Citation: Jc. Fruchart et al., New conceptions in the mechanism of action of fibrates and prospective therapeutics in atherosclerosis, B ACA N MED, 185(1), 2001, pp. 63-75
Potential role of drug combinations in the prevention of cardiovascular disease
Authors: Fruchart, JC Duriez, P
Citation: Jc. Fruchart et P. Duriez, Potential role of drug combinations in the prevention of cardiovascular disease, EUR H J SUP, 2(D), 2000, pp. D54-D56
4-Mercaptoimidazoles derived from the naturally occurring antioxidant ovothiols 1. Antioxidant properties
Authors: Zoete, V Bailly, F Vezin, H Teissier, E Duriez, P Fruchart, JC Catteau, JP Bernier, JL
Citation: V. Zoete et al., 4-Mercaptoimidazoles derived from the naturally occurring antioxidant ovothiols 1. Antioxidant properties, FREE RAD RE, 32(6), 2000, pp. 515
Alternative splicing of Xenopus alpha(fast)-tropomyosin pre-mRNA during development: Identification of determining sequences
Authors: Duriez, P Lesimple, M Allo, MR Hardy, S
Citation: P. Duriez et al., Alternative splicing of Xenopus alpha(fast)-tropomyosin pre-mRNA during development: Identification of determining sequences, DNA CELL B, 19(6), 2000, pp. 365-376
Paraoxonase activity is dramatically decreased in patients positive for anticardiolipin antibodies
Authors: Lambert, M Boullier, A Hachulla, E Fruchart, JC Teissier, E Hatron, PY Duriez, P
Citation: M. Lambert et al., Paraoxonase activity is dramatically decreased in patients positive for anticardiolipin antibodies, LUPUS, 9(4), 2000, pp. 299-300
Phenylpropanoids from Ballota nigra L. inhibit in vitro LDL peroxidation
Authors: Seidel, V Verholle, M Malard, Y Tillequin, F Fruchart, JC Duriez, P Bailleul, F Teissier, E
Citation: V. Seidel et al., Phenylpropanoids from Ballota nigra L. inhibit in vitro LDL peroxidation, PHYTOTHER R, 14(2), 2000, pp. 93-98
Antioxidant properties of di-tert-butylhydroxylated flavonoids
Authors: Lebeau, J Furman, C Bernier, JL Duriez, P Teissier, E Cotelle, N
Citation: J. Lebeau et al., Antioxidant properties of di-tert-butylhydroxylated flavonoids, FREE RAD B, 29(9), 2000, pp. 900-912
Oxidized phospholipids activate PPAR alpha in a phospholipase A2-dependentmanner
Authors: Delerive, P Furman, C Teissier, E Fruchart, JC Duriez, P Staels, B
Citation: P. Delerive et al., Oxidized phospholipids activate PPAR alpha in a phospholipase A2-dependentmanner, FEBS LETTER, 471(1), 2000, pp. 34-38
Absence of relationship between plasma Lp(a), Lp-AI, anti-oxidized LDL autoantibodies, LDL immune complexes concentrations and restenosis after percutaneous transluminal coronary angioplasty
Authors: Boullier, A Walters-Laporte, E Hamon, M Tailleux, A Amant, C Amouyel, P Fruchart, JC Bertrand, M Duriez, P
Citation: A. Boullier et al., Absence of relationship between plasma Lp(a), Lp-AI, anti-oxidized LDL autoantibodies, LDL immune complexes concentrations and restenosis after percutaneous transluminal coronary angioplasty, CLIN CHIM A, 299(1-2), 2000, pp. 129-140
Paraoxonase polymorphism (Gln192Arg) as a determinant of the response of human coronary arteries to serotonin
Authors: Bauters, C Amant, C Boulier, A Cabrol, P McFadden, E Duriez, P Bertrand, ME Amouyel, P
Citation: C. Bauters et al., Paraoxonase polymorphism (Gln192Arg) as a determinant of the response of human coronary arteries to serotonin, CIRCULATION, 101(7), 2000, pp. 740-743
Paraoxonase activity is reduced by a pro-atherosclerotic diet in rabbits (vol 269, pg 232, 2000)
Authors: Mackness, M Boullier, A Hennuyer, N Mackness, B Hall, M Tailleux, A Duriez, P Delfly, B Durrington, P Fruchart, JC Duverger, N Caillaud, JM Castro, G
Citation: M. Mackness et al., Paraoxonase activity is reduced by a pro-atherosclerotic diet in rabbits (vol 269, pg 232, 2000), BIOC BIOP R, 270(2), 2000, pp. 676-676
Paraoxonase activity is reduced by a pro-atherosclerotic diet in rabbits
Authors: Mackness, N Bouiller, A Hennuyer, N Mackness, B Hall, M Tailleux, A Duriez, P Delfly, B Durrington, P Fruchart, JC Duverger, N Caillaud, JM Castro, G
Citation: N. Mackness et al., Paraoxonase activity is reduced by a pro-atherosclerotic diet in rabbits, BIOC BIOP R, 269(1), 2000, pp. 232-236
Peroxisome proliferator-activated receptor-alpha activators regulate genesgoverning lipoprotein metabolism, vascular inflammation and atherosclerosis
Authors: Fruchart, JC Duriez, P Staels, B
Citation: Jc. Fruchart et al., Peroxisome proliferator-activated receptor-alpha activators regulate genesgoverning lipoprotein metabolism, vascular inflammation and atherosclerosis, CURR OP LIP, 10(3), 1999, pp. 245-257
Structure-activity relationships in a series of melatonin analogues with the low-density lipoprotein oxidation model
Authors: Gozzo, A Lesieur, D Duriez, P Fruchart, JC Teissier, E
Citation: A. Gozzo et al., Structure-activity relationships in a series of melatonin analogues with the low-density lipoprotein oxidation model, FREE RAD B, 26(11-12), 1999, pp. 1538-1543
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
Authors: Lechat, P Brunhuber, KW Hofmann, R Kuhn, P Nesser, HJ Slany, J Weihs, W Wiedermann, C Wimmer, H van Mieghem, W Boland, J Chaudron, JM Jordaens, L Melchior, JP Aschermann, M Bruthansl, J Hradec, M Kolbel, F Semrad, B Haghfelt, T Fischer-Hansen, J Goetzsche, CO Hildebrandt, P Kassis, E Rasmussen, V Rokkedal, J Thomassen, A Groundstroem, K Uusimaa, P Le Heuzey, JY Aumont, MC Aupetit, JF Baille, N Baudouy, P Belin, A Bonneau, A Bonneric, G Bousser, JP Citron, B Dary, P Decoulx, E De Groote, P Denolle, T Dievart, F Duriez, P Eicher, JC Enjuto, G Ferriere, M Fournier, E Garandeau, M Gauthier, J Genest, M Gerbe, A Godenir, JP Guillot, B Guillot, JP Guillot, P Heno, P d'Ivernois, C Jean, M Kacet, S Kalle, R Komajda, M Lacroix, A Lallemand, R Lardoux, H Marquet, M Martin, M Martin, O Mery, D Mossaz, R Mothes, P Olive, T Ostorero, M Paganelli, F Page, E Pauly-Laubry, C Puel, J Rousseau, JF Roux, JJ Schenowitz, A Sourdais, K Tremel, F Verdun, A Witchiz, S Wolf, JE Hombach, V Assmann, I Beyer, T Bischoff, KO Darius, H Ertl, G Fleck, E Forster, K Freytag, F Gleichmann, U Haasis, R Henssge, R Hey, D Hesse, P Hofs, T Keck, M Klein, H Kromer, ET Kruls-Munch, J Luderitz, B Maisch, B Mitrovic, V Neubauer, S Osterziel, KJ Simon, H Spitzer, SG Stohring, R Taubert, G Teichmann, W Theisen, K Wende, W Wieser, H Zotz, R Preda, I Csanady, M Cserhalmi, L Edes, I Gesztesi, T Karpati, P Simon, K Tarjan, J Fogari, R Tramarin, R Galie, N Giani, P Milanese, U Scalvini, S Scrutinio, D Sechi, LA Tettamanti, F De Vito, F Crean, P McCann, H Mulcahy, D Sugrue, D van Hoogenhuyze, DCA van der Burgh, PH Ciampricotti, R van Dantzig, JM DenHartog, FR Henneman, JA van Kesteren, HAM Kragten, JA Liem, KL Limburg, A van der Linde, MR Linssen, GCM Pasteuning, H Penn, HJAM Van Rossum, P Schaafsma, HJ Schelling, A Sloos, R Wesdorp, JCL Korewicki, J Achremczyk, P Czestockowska, E Dowgird, M Dyduszynski, A Gorski, J Ilmurzynska, K Janicki, K Kornacewicz-Jach, Z Kraska, T Krzeminska-Pakula, M Kuch, J Nartowicz, E Petelenz, T Piwowarska, W Rawczynska-Englert, I Ruzyllo, W Swiatecka, G Tendera, M Wierzchowiecki, M Wodniecki, J Wojciechowoski, D Wrabec, K Wysocki, H Gomes, RS Ceia, MF Lousada, N Campos, JMM Providencia, LA de Moura, ALZC Marejev, VJ Aronov, DM Arutjunov, GP Bart, BJ Basechikin, SS Belenkov, JN Beloussov, JB Bokeria, OA Charchogljan, RA Doschytsin, V Fedorova, TA Glezer, MG Gorbachenkov, A Gorshkov, VA Gospodarenko, AL Ivashkin, VT Ivleva, AJ Kyrichenko, AA Lavrov, AA Lazebnik, LB Marynov, A Mazaev, VP Polejev, NR Shpektor, A Sidorenko, BA Sobolev, KE Starodoubtsev, AK Storozhakhov, GI Syrkin, AL Zodionchenko, VS Zvereva, TV Murin, J Kaliska, G Rybar, R Valle, V Artaza, M Conthe, P Cruz, JM Garcia-Moll, M Lopez-Sendon, JL Martinez, A Monzon, F Ribas, M Roig, E Roldan, I Hoglund, C Ekdahl, S Hjelmaeus, L Lindberg, K Lofdahl, P Ulvenstam, G Warselius, L Follath, F Anghern, W Dubach, P Erne, P Gallino, A Moccetti, T Bridges, A Adgey, J Ambepitiya, G Boon, N Boyle, RM Cowley, AJ Cripps, T Davies, MK Dunn, F Findlay, J Forsey, P Fyfe, T Gould, B Greenwood, TW Hubner, P Khan, S Lewis, P Mackay, A Maltz, M McArthur, J McLeod, A McLeod, D Metcalfe, M Millar-Craig, M Mills, P Nelson, JK Nicholls, D Oakley, GD Patterson, DLH Pohl, JEF Ray, S Silke, B Wilkinson, PR Jmouro, AV
Citation: P. Lechat et al., The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial, LANCET, 353(9146), 1999, pp. 9-13
Monocyte tissue factor response is decreased in patients with hyperlipidemia
Authors: Rugeri, L Susen, S Bard, JM Corseaux, D Gaveriaux, V Devos, P Lecerf, JM Duriez, P Jude, B
Citation: L. Rugeri et al., Monocyte tissue factor response is decreased in patients with hyperlipidemia, THROMB RES, 96(4), 1999, pp. 283-292
Risultati: 1-25 | 26-30